210 related articles for article (PubMed ID: 19817448)
21. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
Liu Q; Zhang J; Xia W; Gu H
Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
[TBL] [Abstract][Full Text] [Related]
22. In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles.
Park MV; Annema W; Salvati A; Lesniak A; Elsaesser A; Barnes C; McKerr G; Howard CV; Lynch I; Dawson KA; Piersma AH; de Jong WH
Toxicol Appl Pharmacol; 2009 Oct; 240(1):108-16. PubMed ID: 19631676
[TBL] [Abstract][Full Text] [Related]
23. Isomer-dependent adsorption and release of cis- and trans-platin anticancer drugs by mesoporous silica nanoparticles.
Tao Z; Xie Y; Goodisman J; Asefa T
Langmuir; 2010 Jun; 26(11):8914-24. PubMed ID: 20148511
[TBL] [Abstract][Full Text] [Related]
24. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes.
Fisichella M; Dabboue H; Bhattacharyya S; Saboungi ML; Salvetat JP; Hevor T; Guerin M
Toxicol In Vitro; 2009 Jun; 23(4):697-703. PubMed ID: 19254755
[TBL] [Abstract][Full Text] [Related]
25. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
Lin YS; Haynes CL
J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
[TBL] [Abstract][Full Text] [Related]
26. In vitro toxicity of silica nanoparticles in human lung cancer cells.
Lin W; Huang YW; Zhou XD; Ma Y
Toxicol Appl Pharmacol; 2006 Dec; 217(3):252-9. PubMed ID: 17112558
[TBL] [Abstract][Full Text] [Related]
27. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles.
Thomas MJ; Slipper I; Walunj A; Jain A; Favretto ME; Kallinteri P; Douroumis D
Int J Pharm; 2010 Mar; 387(1-2):272-7. PubMed ID: 20025947
[TBL] [Abstract][Full Text] [Related]
28. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis.
Lee S; Yun HS; Kim SH
Biomaterials; 2011 Dec; 32(35):9434-43. PubMed ID: 21889200
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticles of mesoporous SO3H-functionalized Si-MCM-41 with superior proton conductivity.
Marschall R; Bannat I; Feldhoff A; Wang L; Lu GQ; Wark M
Small; 2009 Apr; 5(7):854-9. PubMed ID: 19226596
[TBL] [Abstract][Full Text] [Related]
30. High surface area Au-SBA-15 and Au-MCM-41 materials synthesis: tryptophan amino acid mediated confinement of gold nanostructures within the mesoporous silica pore walls.
Selvakannan P; Mantri K; Tardio J; Bhargava SK
J Colloid Interface Sci; 2013 Mar; 394():475-84. PubMed ID: 23351474
[TBL] [Abstract][Full Text] [Related]
31. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins.
Slowing II; Trewyn BG; Lin VS
J Am Chem Soc; 2007 Jul; 129(28):8845-9. PubMed ID: 17589996
[TBL] [Abstract][Full Text] [Related]
32. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
33. Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy.
Hocine O; Gary-Bobo M; Brevet D; Maynadier M; Fontanel S; Raehm L; Richeter S; Loock B; Couleaud P; Frochot C; Charnay C; Derrien G; Smaïhi M; Sahmoune A; Morère A; Maillard P; Garcia M; Durand JO
Int J Pharm; 2010 Dec; 402(1-2):221-30. PubMed ID: 20934496
[TBL] [Abstract][Full Text] [Related]
34. The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation.
Rabolli V; Thomassen LC; Uwambayinema F; Martens JA; Lison D
Toxicol Lett; 2011 Oct; 206(2):197-203. PubMed ID: 21803137
[TBL] [Abstract][Full Text] [Related]
35. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery.
Park IY; Kim IY; Yoo MK; Choi YJ; Cho MH; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):280-7. PubMed ID: 18490119
[TBL] [Abstract][Full Text] [Related]
36. Implication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cells.
Passagne I; Morille M; Rousset M; Pujalté I; L'azou B
Toxicology; 2012 Sep; 299(2-3):112-24. PubMed ID: 22627296
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells.
Heikkilä T; Santos HA; Kumar N; Murzin DY; Salonen J; Laaksonen T; Peltonen L; Hirvonen J; Lehto VP
Eur J Pharm Biopharm; 2010 Mar; 74(3):483-94. PubMed ID: 20025968
[TBL] [Abstract][Full Text] [Related]
38. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
39. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells.
Li Y; Sun L; Jin M; Du Z; Liu X; Guo C; Li Y; Huang P; Sun Z
Toxicol In Vitro; 2011 Oct; 25(7):1343-52. PubMed ID: 21575712
[TBL] [Abstract][Full Text] [Related]
40. Molecular Elucidation of Biological Response to Mesoporous Silica Nanoparticles in Vitro and in Vivo.
Chou CC; Chen W; Hung Y; Mou CY
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22235-22251. PubMed ID: 28608695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
